Xiaofan Jiang Selected Research

Xiaofan Jiang Research Topics

Disease

6	Neoplasms (Cancer) 10/2022 - 12/2007
5	Glioma (Gliomas) 10/2022 - 12/2007
4	Carcinogenesis 01/2022 - 03/2010
4	Brain Ischemia (Cerebral Ischemia) 08/2014 - 04/2006
4	Neoplasm Metastasis (Metastasis) 08/2014 - 12/2007
3	Inflammation (Inflammations) 04/2022 - 01/2020
3	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2022 - 04/2012
3	Nasopharyngeal Carcinoma 08/2014 - 04/2013
3	Lymphatic Metastasis 08/2014 - 04/2013
2	Insulin Resistance 04/2022 - 01/2021
2	Ischemia 08/2014 - 06/2014
2	T-Cell Lymphoma (Lymphoma, T Cell) 03/2011 - 03/2010
2	Stroke (Strokes) 12/2010 - 04/2006
2	Ischemic Stroke 12/2010 - 04/2006
1	Sepsis (Septicemia) 07/2022
1	Cerebrospinal Fluid Leak 06/2022
1	Infections 06/2022
1	Neuroinflammatory Diseases 05/2022
1	Wounds and Injuries (Trauma) 05/2022
1	Cerebral Hemorrhage 05/2022
1	Starvation 04/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2022
1	Hyperglycemia 04/2022
1	Myopia 01/2022
1	Brain Infarction 01/2022
1	Rheumatoid Arthritis 10/2021
1	Intracranial Aneurysm (Cerebral Aneurysm) 10/2021
1	Obesity 01/2021
1	Weight Loss (Weight Reduction) 01/2018
1	Aneurysm (Aneurysms) 05/2016
1	Trigeminal Neuralgia (Tic Douloureux) 06/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2014
1	Nasopharyngitis 08/2014
1	Glioblastoma (Glioblastoma Multiforme) 11/2013
1	Neurologic Manifestations (Neurological Manifestations) 10/2013
1	Brain Injuries (Brain Injury) 10/2013
1	Brain Edema (Cerebral Edema) 10/2013
1	Astrocytoma (Pilocytic Astrocytoma) 03/2011
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2010
1	Edema (Dropsy) 12/2010
1	Infarction (Infarctions) 12/2010

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2010
3	ResveratrolIBA 08/2014 - 04/2006
3	Neuroprotective AgentsIBA 08/2014 - 12/2010
2	Caspase 3 (Caspase-3)IBA 05/2022 - 08/2014
2	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2021
2	Untranslated RNA (Noncoding RNA)IBA 01/2022 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2011
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	Circular RNAIBA 10/2022
1	Disinfectants (Biocides)IBA 07/2022
1	Sirtuin 3IBA 05/2022
1	ProteomeIBA 04/2022
1	palmitoleic acidIBA 04/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 10/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	Armadillo Domain ProteinsIBA 01/2021
1	AdiponectinIBA 01/2021
1	EndotoxinsIBA 01/2020
1	IceIBA 01/2018
1	MM 36IBA 05/2016
1	prolinedithiocarbamate (PDTC)IBA 08/2014
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 08/2014
1	NOC 18IBA 08/2014
1	VimentinIBA 08/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2014
1	hydroxide ionIBA 08/2014
1	Phosphotransferases (Kinase)IBA 08/2014
1	Protein Kinases (Protein Kinase)IBA 08/2014
1	pyrrolidineIBA 08/2014
1	Cadherins (E-Cadherin)IBA 08/2014
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2014
1	U 0126 (UO 126)IBA 06/2014
1	glaucocalyxin AIBA 11/2013
1	Potassium Channels (Potassium Channel)IBA 10/2013
1	sodium bisulfide (NaHS)IBA 10/2013
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2013
1	Adenosine Triphosphate (ATP)IBA 10/2013
1	Carrier Proteins (Binding Protein)IBA 09/2013
1	Ubiquitin-Conjugating EnzymesIBA 04/2013
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2012
1	CateninsIBA 03/2011
1	Interleukin-8 (Interleukin 8)IBA 12/2010
1	osthol (osthole)IBA 12/2010
1	diazonaphthalenedisulfonic acid (NDS)IBA 12/2010
1	triphenyltetrazoliumIBA 12/2010
1	beta CateninIBA 03/2010
1	AntioxidantsIBA 12/2007
1	CurcuminIBA 12/2007

Therapy/Procedure

2	Biological Therapy 03/2011 - 03/2010
1	Bed Rest (Bedrest) 06/2022
1	Therapeutics 01/2022
1	Microvascular Decompression Surgery 06/2015